Olema Pharmaceuticals Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -980.7% | – | – | – | -7,220.9% | – | – | – | – | – | – | – | |
| – | 4.7% | – | – | – | 31.9% | – | – | – | – | – | – | – | |
| – | 230.9% | – | – | – | 1,737.1% | – | – | – | – | – | – | – | |
| – | 308.1% | – | – | – | 597.8% | – | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| – | -1,640.9% | – | – | – | -31,435.2% | – | – | – | – | – | – | – | |
| – | 27.8% | – | – | – | 67,115.4% | – | – | – | – | – | – | – | |
| – | -2,593.8% | – | – | – | 28,459.3% | – | – | – | – | – | – | – | |
| – | -980.7% | – | – | – | -7,220.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.